715 SP 15 (Univasc 15 mg)

Generic Name: moexipril

Pill imprint 715 SP 15 has been identified as Univasc 15 mg.

Univasc is used in the treatment of high blood pressure; heart attack; left ventricular dysfunction; heart failure; diabetic kidney disease and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Univasc 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 715 SP 15

Univasc 15 mg 715 SP 15
Univasc 15 mg 715 SP 15 Front
Univasc 15 mg 715 SP 15 Back
Univasc 15 mg 715 SP 15
Univasc
Generic Name:
moexipril
Imprint:
715
SP 15
Strength:
15 mg
Color:
Pink
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Schwarz Pharma
National Drug Code (NDC):
00091-3715
Inactive Ingredients:
lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose (type h)
hypromelloses
polyethylene glycol 6000
titanium dioxide
ferric oxide red
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-4276 A S Medication Solutions LLC (repackager)
54868-4088 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)